q4

q4

by Laura Koth -
Number of replies: 3

part d is asking for a prob but my answers from a,b and c would result in the following to be true :

Note that if CBOP is more than BBOP, this gives a PTT > 1, meaning even if you have the disease you would be below the treatment threshold; i.e., you should not treat.

so can you help me understand question d

1. are you saying that bbop is $500 per day? yes/no?

2. the cost in b is given per month, so do we need to divide by 30 days? maybe that is why my cost is > benefit?

In reply to Laura Koth

Re: q4

by Hyelee Kim -

I also have some questions regarding question 4-b.

b.) Fremanezumab costs about $600/monthly dose.   It was well tolerated in the trial.  If we ignore possible late adverse effects and focus only on the medication cost, what is the approximate cost per month per patient who achieved a 50% reduction in headache days? 

We were not given any information regarding the 50% reduction in headache days. Does it mean at least a 50% reduction in headache days?

Thank you!


In reply to Laura Koth

Re: q4

by Samuel Washington -

Hi Laura,

I think for this question I would evaluate what has been given within the context of this problem.

1) "it is worth $500 to prevent one headache day" -- this tells us the value of preventing one headache day, right?

2) I think you are exactly right to focus on the units to ensure you are comparing "apples" to "apples". And you will have that value already calculated by part d.


I hope this helps!


Sam